INTRODUCTION: Targeted α therapy (TAT) in mCRPC is a rapidly advancing class of radiotherapeutics that can effectively deliver potent and local radiation selectively to cancer cells while sparing the ...

Cancer Immunol Res (2026) 14 (2_Supplement): C008.

Cancer Res (2026) 86 (8_Supplement): LB407.

Abstract:. China has approved the first CAR T-cell therapy that targets solid tumors, satricabtagene autoleucel (satri-cel), for patients with claudin 18.2–positive, HER2-negative gastric or ...

Cancer Res (2023) 83 (8_Supplement): CT152. Background: MET gene amplification is associated with poor prognosis in gastric cancer (GC) and gastroesophageal junction adenocarcinomas (GEJ). Savolitinib ...

You do not currently have access to this content.

Background: Patients (pts) with advanced/metastatic triple-negative breast cancer (a/mTNBC) have limited treatment options and poor prognosis. Immune checkpoint inhibitors combined with chemotherapy ...

Cancer Res (2023) 83 (7_Supplement): ND02.

Abstract. ADAM9 (A Disintegrin And Metalloproteinase 9) is a transmembrane metalloproteinase overexpressed in a wide range of solid tumors, where it promotes tumor progression, metastasis, and poor ...

Introduction: Epigallocatechin gallate (EGCG) is a polyphenol present in green tea that is known for its anti-oxidant, anti-inflammatory, anti-angiogenic, pro-apoptotic, and anti-cancer properties.

Mol Cancer Ther (2023) 22 (12_Supplement): PR010. Methods: Patients with previously treated, advanced KRAS G12X mutant solid tumors were enrolled at escalating doses of single agent RMC-6236 ...

AbstractChimeric antigen receptor (CAR) T-cell therapy has shown early promise against glioblastoma, which lacks effective treatment options. However, two key challenges curtail efficacy: ...